CDK4 and melanoma: As estimates have suggested that POT1 may be the second major high-penetrance melanoma susceptibility gene after CDKN2A, being causal of disease predisposition in 2%–4% of CDKN2A/CDK4-negative families,10 14 it has been included in multiple panels for genetic testing of melanoma families.